Mark David Pass MD

Geriatrics•Marlboro, NJ

Hospice and Palliative Medicine

Jersey Shore Geriatrics

Join to View Full Profile

15 School Road EastSuite 2Marlboro, NJ 07746
Phone+1 732-866-9922
Fax+1 732-866-9970

Summary

Dr. Mark Pass is a geriatrician in Marlboro, NJ and is affiliated with multiple hospitals in the area, including Hackensack Meridian Health Jersey Shore University Medical Center and Hackensack Meridian Health Ocean Medical Center. He received his medical degree from American University of the Caribbean School of Medicine and has been in practice 18 years. He specializes in hospice and palliative medicine and is experienced in dementia.

Education & Training

Jersey Shore University Medical CenterFellowship, Geriatric Medicine (Internal Medicine), 2002 - 2003
Jersey Shore University Medical CenterResidency, Internal Medicine, 1999 - 2002
American University of the Caribbean School of MedicineClass of 1999
American University of the CaribbeanMSc, 1997
University of FloridaBS, 1995

Certifications & Licensure

NJ State Medical License 2002 - 2025

Awards, Honors, & Recognition

New Jersey Monthly Top Doctor 2013-2017
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA) Start of enrollment: 2013 Feb 01
Completed
Phase 4
Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection Start of enrollment: 2013 Jul 30
Terminated
Phase 3
Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study Start of enrollment: 2016 Feb 01
Completed

Publications & Presentations

Abstracts/Posters

The efficacy of rivastigmine for treatment of agitation in non-demented elderly patients.
Lee PP, Shua-Haim JR, Pass MD, Sabo, M, Smith JS, Patel SR, Patel SR, JAMDA, 1/1/2004
Safety and efficacy of dronabinol treatment for weight loss in Alzheimer's disease (AD) patients taking acetylcholinesterase inhibitors who are resistant to megestrol:...
Patel SR, Shua-Haim JR, Pass MD, JAGS, 1/1/2004
An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease.
Shua-Haim JR, Pass MD, Smith JS, Lee PP, JAGS, 1/1/2004
Results of a next day crossover study of donepezil to galantamine in Alzheimer's disease patients: A one-month follow up study.
Smith JS, Shua-Haim JR, Pass MD, Lee PP, Patel P, JAGS, 1/1/2004
Mortality after hip fracture repair in demented patients: 3 month follow up after hospital discharge.
Smith JS, Shua-Haim JR, Pass MD, JAGS, 1/1/2004
Novel treatments for agitation in advanced Alzheimer's disease: rivastigmine and dronabinol.
Pass MD, Shua-Haim JR, JAMDA, 1/1/2003
Hypersexuality in a female with Alzheimer's disease: a case report.
Patel S, Shua-Haim JR, Pass MD, JAMDA, 1/1/2003
Results of a one week overlap-crossover from donepezil to galantamine in Alzheimer's disease patients: a one-month follow up study.
Pass MD, Shua-Haim JR, JAGS, 1/1/2003
Sertraline in the treatment of mild Alzheimer's disease: the clinical and caregiver's impression.
Smith JM, Shua-Haim JR, Pass MD, JAGS, 1/1/2003
A new mechanism of peroneal nerve compression.
Pass MD, Rossi RA, Casey KK, American College of PhysiciansAmerican Society of Internal Medicine New Jersey Chapter Regional Meeting, 1/1/2002
Join now to see all